Anne Kathrin Volkmer

The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

Stephen B. Willingham, Jens-Peter Volkmer, Andrew J. Gentles et al. · Proceedings of the National Academy of Sciences · 2012 · 1.7K citations · Full text

Medicine, Immunology, Oncology +17

Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies

Kipp Weiskopf, Aaron M. Ring, Chia Chi M. Ho et al. · Science · 2013 · 494 citations · Full text

Life Sciences, Immunology, Oncology +17

CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer

Kipp Weiskopf, Nadine S. Jahchan, Peter J. Schnorr et al. · Journal of Clinical Investigation · 2016 · 431 citations · Full text

Medicine, Immunology, Oncology +13

Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma

Badreddin Edris, Kipp Weiskopf, Anne Kathrin Volkmer et al. · Proceedings of the National Academy of Sciences · 2012 · 256 citations · Full text

Medicine, Immunology, Oncology +17

Hysteroscopic Management of Residual Trophoblastic Tissue Is Superior to Ultrasound-Guided Curettage

Daniel Rein, Torsten C. Schmidt, A.P. Hess et al. · Journal of Minimally Invasive Gynecology · 2011 · 173 citations

Medicine, Gynecology, Surgery +13